Evidence map›Paper›PMID 41072016›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

Anti-vimentin antibody mitigates SARS-CoV-2 spike protein-induced fibroblast activation and fibrosis.

Łukasz Suprewicz, Alicja Walewska, Paulina Paprocka, Paul A Janmey, Robert Bucki

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Łukasz SuprewiczDepartment of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, United States.
Alicja WalewskaCentre of Regenerative Medicine, Medical University of Bialystok, Bialystok, Poland.
Paulina PaprockaDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Paul A JanmeyDepartment of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, United States.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Bialystok, Poland.

Funding

Pathological consequences of altered tissue mechanics in fibrosisR01EB017753 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A, SHENOY, VIVEK · 2014 to 2025
$6.3M
Molecular function of extracellular vimentin in regulating the response to lens woundingR01EY035771 · NEI · THOMAS JEFFERSON UNIVERSITY · PI Paul A Janmey, Janice Lynn Walker · 2024 to 2026
$1.4M
Foundation for Polish Science FNP START 075/2024Medical University of Bialystok B.SUB.24.409Medical University of Bialystok EB017753Medical University of Bialystok EY035771Medical University of Bialystok RPOWP 2007-2013Medical University of Bialystok UDA- RPPD.01.01.00-20-001/15-00Ministry of Science and Higher EducationNEI NIH HHS R01 EY035771NIBIB NIH HHS R01 EB017753NIH HHSRegional Initiative of Excellence in 2019-2022 024/RID/2018/19
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41072016
PMCPMC12958411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.